Form 483

Nomax, Inc. Form 483, 2012-01-31

FDA issued a Form 483 to Nomax, Inc. on 2012-01-31 with 9 public-safe observations.

483· Form 483 issued9 observations

Nomax, Inc. · Saint Louis, United States · Issued January 31, 2012

Overview

  • 9 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

31 Jan 2012
21 CFR 211.84(d)(2)

Reports of Analysis (Components)

Cited by Michele Perry Williams, Jeffery L Sumter

31 Jan 2012
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Michele Perry Williams, Jeffery L Sumter

31 Jan 2012
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Michele Perry Williams, Jeffery L Sumter

31 Jan 2012
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Michele Perry Williams, Jeffery L Sumter

31 Jan 2012
21 CFR 211.160(b)(4)

Establishment of calibration procedures

Cited by Michele Perry Williams, Jeffery L Sumter

Inspected site

NINomax, Inc.Saint Louis, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.170(b)Cited across public-safe Form 483 observations2x
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.188(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.100(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere